TGM2 and cancer: Mechanistic in vitro and in vivo studies demonstrated that TG2-dependent degradation of protein phosphatase 2 (PP2A-α) activated the expression of MMP-2 in a cAMP-response element-binding protein (CREB)-dependent fashion, leading to cancer progression [74].